FONTANELLA, ROSARIA ANNA
 Distribuzione geografica
Continente #
EU - Europa 295
AS - Asia 214
NA - Nord America 91
SA - Sud America 22
AF - Africa 2
Totale 624
Nazione #
RU - Federazione Russa 163
US - Stati Uniti d'America 86
SG - Singapore 78
IT - Italia 61
CN - Cina 60
DE - Germania 25
IE - Irlanda 20
BR - Brasile 19
IN - India 19
HK - Hong Kong 18
KR - Corea 16
VN - Vietnam 10
FI - Finlandia 9
JP - Giappone 7
AT - Austria 5
CZ - Repubblica Ceca 3
DK - Danimarca 2
FR - Francia 2
HN - Honduras 2
NL - Olanda 2
PK - Pakistan 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BO - Bolivia 1
CA - Canada 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GB - Regno Unito 1
KG - Kirghizistan 1
LT - Lituania 1
PR - Porto Rico 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 624
Città #
Moscow 61
Singapore 42
Naples 27
Hefei 24
Santa Clara 23
Dublin 20
Hong Kong 18
Bengaluru 17
Munich 17
Seoul 16
Ashburn 8
Los Angeles 8
Beijing 7
Turku 7
Nuremberg 6
Hanoi 4
Vienna 4
Aversa 3
Brno 3
Dallas 3
Ercolano 3
Ho Chi Minh City 3
New York 3
Pomigliano d'Arco 3
Rome 3
The Dalles 3
Amsterdam 2
Council Bluffs 2
Florence 2
Juelsminde 2
Pian di Scò 2
São Paulo 2
Viterbo 2
Americana 1
Ankara 1
Araraquara 1
Araxá 1
Atlanta 1
Avellino 1
Baronissi 1
Bishkek 1
Biên Hòa 1
Boston 1
Brooklyn 1
Buenos Aires 1
Capua 1
Carapicuíba 1
Carinaro 1
Caserta 1
Cercola 1
Charlotte 1
Chennai 1
Chicago 1
El Progreso 1
Faisalabad 1
Falkenstein 1
Gorodets 1
Guayaquil 1
Helsinki 1
Imbituva 1
Johannesburg 1
Joinville 1
Katy 1
Lappeenranta 1
London 1
Manassas 1
Mobile 1
Montreal 1
Nilópolis 1
Nocera Superiore 1
Olinda 1
Pacajus 1
Paris 1
Port Elizabeth 1
Porto Alegre 1
Pune 1
Quảng Ngãi 1
Ribeirão Preto 1
Rio de Janeiro 1
Santa Cruz 1
Santa Rosa de Viterbo 1
Santana do Ipanema 1
Santiago de los Caballeros 1
Seattle 1
Secaucus 1
Somma Vesuviana 1
São Gabriel da Palha 1
São Vicente 1
Tangará da Serra 1
Tashkent 1
Tegucigalpa 1
Thái Nguyên 1
Tokyo 1
Vilnius 1
Yabucoa 1
Zurich 1
Totale 413
Nome #
Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors 89
Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide 80
Potential Role of Lisinopril in Reducing Atherosclerotic Risk: Evidence of an Antioxidant Effect in Human Cardiomyocytes Cell Line 72
Evidence that tirzepatide protects against diabetes-related cardiac damages 68
Targeting redox imbalance in neurodegeneration: characterizing the role of GLP-1 receptor agonists 68
Tirzepatide prevents neurodegeneration through multiple molecular pathways 61
Obesity-induced neuronal senescence: Unraveling the pathophysiological links 59
Myocardial sodium–glucose cotransporter 2 expression and cardiac remodelling in patients with severe aortic stenosis: The BIO-AS study 58
Is it time to revise the fighting strategy toward type 2 diabetes? Sex and pollution as new risk factors 55
Adipose-tumor crosstalk in colorectal cancer: Identifying (Epi)genetic biomarkers for tumor progression and cachexia 41
Totale 651
Categoria #
all - tutte 2.538
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.538


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202323 0 0 0 0 0 0 3 6 14 0 0 0
2023/202445 0 3 2 3 5 4 0 2 7 3 1 15
2024/2025186 8 1 2 9 31 32 31 11 9 16 16 20
2025/2026397 49 63 44 35 86 120 0 0 0 0 0 0
Totale 651